These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 125430)

  • 1. Biogenic amines and the effect of short term lithium administration on open field activity in rats.
    Smith DF
    Psychopharmacologia; 1975; 41(3):295-300. PubMed ID: 125430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lithium on brain 5-hydroxytryptamine metabolism in mice.
    Shaw JP; Ratcliffe F
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):116-24. PubMed ID: 136232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rat brain monoamine metabolism following the acute administration of lithium chloride in combination with antidepressant drugs.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):202-7. PubMed ID: 1164088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various doses of lithium on the level of biogenic amines in discrete areas of rat brain.
    Khan SA; Hasan M
    Indian J Med Res; 1979 Mar; 69():489-94. PubMed ID: 447388
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in mouse brain serotonin turnover following chronic imipramine administration.
    Hall TR; Urueña G; Figueroa HR
    Gen Pharmacol; 1985; 16(1):55-9. PubMed ID: 2579874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effect of chloropromazine, imipramine and lithium chloride on monoamine oxidase activity in rat brain mitochondria.
    Nag M; Nandi N
    Biosci Rep; 1987 Sep; 7(9):701-4. PubMed ID: 2827805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats.
    Berggren U
    J Neural Transm; 1985; 64(3-4):239-50. PubMed ID: 4086991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pargyline on hypothalamic biogenic amines and serum prolactin. LH and TSH in male rats.
    Chen HT; Simpkins JW; Mueller GP; Meites J
    Life Sci; 1977 Aug; 21(4):533-41. PubMed ID: 143580
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of the effect of tuftsin on the behavior and on the level of biogenic amines in the brain of rats with differing resistance to acoustic stress].
    Ismaĭlova KhIu; Semenova TP; Iskanderova MD; Fast AE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(6):1043-50. PubMed ID: 9929913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat strain differences in brain monoamine metabolism following para-chlorophenylalanine treatment.
    Emery D; Engel J; Larsson K
    Pharmacol Biochem Behav; 1980 Feb; 12(2):311-2. PubMed ID: 6445566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of lithium on the adrenergic nerve ending.
    Beaty O; Collis MG; Shepherd JT
    J Pharmacol Exp Ther; 1981 Aug; 218(2):309-17. PubMed ID: 6265622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):337-52. PubMed ID: 579062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.